• 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Serum
  • COL3A1 Genes Variations Analysis
  • Fungal Culture, Blood
  • Ehrlichia chaffeensis and Anaplasma Species by Real-Time PCR
  • Legionella pneumophila Antibody, IgM by IFA
  • Chikungunya Virus Antibody, IgM
  • Methyl CpG Binding Protein 2 (MECP2) Gene Mutation Analysis, Rett Syndrome
  • MDA, Urine
  • Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Analysis
  • Gabapentin, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Clinical Utility
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.
Loading...